|
LMBRD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.87539999880238E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.93659998937568E-09 |
| Normal-vs-Stage2 |
9.66740000000188E-05 |
| Normal-vs-Stage3 |
3.463200E-03 |
| Normal-vs-Stage4 |
1.966050E-04 |
| Stage1-vs-Stage2 |
8.145800E-01 |
| Stage1-vs-Stage3 |
3.904200E-01 |
| Stage1-vs-Stage4 |
8.010400E-01 |
| Stage2-vs-Stage3 |
6.724200E-01 |
| Stage2-vs-Stage4 |
6.784200E-01 |
| Stage3-vs-Stage4 |
5.039400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.04559999442233E-09 |
| Normal-vs-AfricanAmerican |
4.12789999959529E-07 |
| Normal-vs-Asian |
2.598000E-03 |
| Caucasian-vs-AfricanAmerican |
9.605800E-01 |
| Caucasian-vs-Asian |
9.212600E-01 |
| AfricanAmerican-vs-Asian |
9.435800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.21589413484935E-12 |
| Normal-vs-Female |
4.220300E-02 |
| Male-vs-Female |
1.237010E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.601210E-03 |
| Normal-vs-Extreme_Weight |
2.5464996777913E-10 |
| Normal-vs-Obese |
1.18969999995944E-06 |
| Normal-vs-Extreme_Obese |
1.53606999999667E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.457960E-01 |
| Normal_Weight-vs-Obese |
7.032400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.274800E-01 |
| Extreme_Weight-vs-Obese |
7.901700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.607400E-01 |
| Obese-vs-Extreme_Obese |
3.891600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.97450000000354E-05 |
| Normal-vs-Age(41-60Yrs) |
3.59489999990359E-07 |
| Normal-vs-Age(61-80Yrs) |
4.77989980929294E-10 |
| Normal-vs-Age(81-100Yrs) |
2.48450000017719E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.134400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.520600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.113800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.688200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.962300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.757000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.63136171238421E-12 |
| Normal-VS-Type2 PRCC |
9.388200E-04 |
| Normal-VS-KIRP CIMP |
3.62879999999954E-05 |
| Normal-VS-Unclassified PRCC |
4.976400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.576800E-03 |
| Type1 PRCC-VS-KIRP CIMP |
8.349000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.323960E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.280400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.490400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.709800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.13070000041083E-07 |
| Normal-vs-N1 |
4.11479999995468E-06 |
| Normal-vs-N2 |
5.699900E-03 |
| N0-vs-N1 |
8.491200E-01 |
| N0-vs-N2 |
9.305400E-01 |
| N1-vs-N2 |
8.221200E-01 |
|
|
